Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
/PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the first patient has been enrolled...